Advanced Materials,
Journal Year:
2023,
Volume and Issue:
36(6)
Published: Oct. 12, 2023
Abstract
Owing
to
low
immunogenicity‐induced
immune
escape
and
short‐term
circulating
responses,
the
efficiency
of
immunotherapy
is
unsatisfactory.
Therefore,
triggering
immunogenic
cell
death
establishing
a
long‐term,
mutually
reinforced
treatment
modality
are
urgent
challenges.
In
this
study,
ultrathin
CaBi
2
Nb
O
9
nanosheets
with
tunable
oxygen
vacancies
(abbreviated
as
CBNO‐OV1)
prepared
for
synergistic
necroptosis
immunotherapy.
The
optimized
vacancy
concentration
significantly
improves
piezoelectric
effect
under
ultrasound
irradiation,
thereby
considerably
improving
generation
reactive
species
(ROS).
Density
functional
theory
shows
that
can
improve
electron
hole
separation
by
suppressing
their
recombination,
thus
resulting
in
enhanced
piezocatalytic
activity.
Moreover,
permeability
tumor
membranes,
Ca
2+
influx.
Additionally,
CBNO‐OV1
also
releases
portion
,
which
induces
assisted
explosive
ROS.
Ribonucleic
acid
transcription
tests
suggest
mechanisms
associated
response
activation
necroptosis.
More
importantly,
trigger
significant
vivo,
activating
macrophage
M1
polarization
through
NF‐kappa
B
pathway
promoting
T‐cell
differentiation.Tumor
Necrosis
Factor‐α
differentiated
from
macrophages
conversely
promotes
necroptosis,
realizing
effect.
This
study
demonstrates
feasibility
amplifying
efficacy.
MedComm – Oncology,
Journal Year:
2024,
Volume and Issue:
3(1)
Published: March 1, 2024
Abstract
Rapid
growth
in
nanoparticles
(NPs)
as
delivery
systems
holds
vast
promise
to
promote
therapeutic
approaches
for
cancer
treatment.
Presently,
a
diverse
array
of
NPs
with
unique
properties
have
been
developed
overcome
different
challenges
and
achieve
sophisticated
routes
enhancement
series
therapies.
Inspiring
advances
achieved
the
field
therapy
using
NPs.
In
this
review,
we
aim
summarize
up‐to‐date
progression
addressing
various
challenges,
expect
elicit
novel
potential
opportunities
alternatively.
We
first
introduce
sorts
NP
technologies,
illustrate
their
mechanisms,
present
applications.
Then,
achievements
made
by
break
obstacles
delivering
cargoes
specific
sites
through
particular
are
highlighted,
including
long‐circulation,
tumor
targeting,
responsive
release,
subcellular
localization.
subsequently
retrospect
recent
research
treatments
from
single
therapy,
like
chemotherapy,
combination
chemoradiotherapy,
integrative
therapy.
Finally,
perspectives
impact
on
oncology
discussed.
believe
review
can
offer
deeper
understanding
ACS Nano,
Journal Year:
2024,
Volume and Issue:
18(2), P. 1516 - 1530
Published: Jan. 3, 2024
Biodegradable
silicate
nanoconstructs
have
aroused
tremendous
interest
in
cancer
therapeutics
due
to
their
variable
framework
composition
and
versatile
functions.
Nevertheless,
low
intratumoral
retention
still
limits
practical
application.
In
this
study,
oxygen
vacancy
(OV)-enriched
bimetallic
nanozymes
with
Fe–Ca
dual
active
sites
via
modification
of
oxidized
sodium
alginate
gallic
acid
(GA)
loading
(OFeCaSA-V@GA)
were
developed
for
targeted
aggregation-potentiated
therapy.
The
band
gap
silica
markedly
decreased
from
2.76
1.81
eV
by
codoping
Fe3+
Ca2+,
enabling
its
excitation
a
650
nm
laser
generate
reactive
species.
OV
that
occurred
the
hydrothermal
synthetic
stage
OFeCaSA-V@GA
can
anchor
metal
ions
form
an
atomic
phase,
offering
massive
fabrication
method
single-atom
nanozymes.
Density
functional
theory
results
reveal
Ca
promote
adsorption
H2O2,
Fe
accelerate
dissociation
thereby
realizing
synergetic
catalytic
effect.
More
importantly,
delivery
induce
morphological
transformation
at
tumor
sites,
leading
high
(the
highest
rate
is
36.3%)
theranostic
components
cells.
Thus,
finding
may
offer
ingenious
protocol
designing
engineering
highly
efficient
long-retention
nanodrugs.
Chemical Science,
Journal Year:
2024,
Volume and Issue:
15(6), P. 1966 - 2006
Published: Jan. 1, 2024
Neoplasias
pose
a
significant
threat
to
aging
society,
underscoring
the
urgent
need
overcome
limitations
of
traditional
chemotherapy
through
pioneering
strategies.
Targeted
drug
delivery
is
an
evolving
frontier
in
cancer
therapy,
aiming
enhance
treatment
efficacy
while
mitigating
undesirable
side
effects.
One
promising
avenue
utilizes
cell
membrane
receptors
like
folate
receptor
guide
transporters
precisely
malignant
cells.
Based
on
cellular
as
hallmark,
targeted
nanocarriers
and
small
molecule-drug
conjugates
have
been
developed
that
comprise
different
(bio)
chemistries
and/or
mechanical
properties
with
individual
advantages
challenges.
Such
modern
folic
acid-conjugated
stimuli-responsive
provide
systemic
controlled
release,
enabling
reduced
dosages,
circumvention
resistance,
diminished
adverse
Since
transporters'
structure-based
Nano TransMed,
Journal Year:
2024,
Volume and Issue:
3, P. 100032 - 100032
Published: Jan. 29, 2024
Nanozymes
exhibit
immense
potential
and
promising
prospects
in
the
realm
of
diagnostic
imaging
tumor
therapy,
owing
to
their
inherent
physicochemical
properties
enzymatic
activities.
With
further
development
application
nanotechnology,
nanozymes
are
expected
become
an
important
tool
field
medicine,
providing
new
solutions
for
disease
diagnosis
treatment.
This
review
provides
overview
recent
studies
over
past
five
years
on
capable
responding
microenvironment
(TME)
multimodal
imaging,
with
a
focus
hypoxia,
acid
pH,
excess
GSH
ROS.
In
addition,
we
present
current
status
several
common
related
contrast
agents,
such
as
MRI/CT,
MRI/PET,
MRI/SPECT,
PET/CT.
Moreover,
some
thoughts
challenges,
future
development,
clinical
translation
microenvironment-responsive
shared.
aims
provide
up-to-date
theranostic
nanomedicine
reference
those
who
fields,
promote
progress
this
interdisciplinary
subject,
accelerate
translation.
Small Science,
Journal Year:
2024,
Volume and Issue:
4(3)
Published: Jan. 17, 2024
Despite
the
great
potential
of
cuproptosis
in
tumor
therapy,
current
cuproptosis‐based
therapy
still
suffers
from
compromised
efficiency
immune
activation.
Pyroptosis,
a
proinflammatory
cell
death
modality,
provides
good
opportunity
to
induce
immunogenic
(ICD)
and
promote
systemic
response.
However,
synergistic
pyroptosis
has
not
been
fully
explored.
Herein,
it
is
discovered
that
Cu(II)‐based
metal–organic
framework
(MOF)
nanoparticles
(NPs)
can
synergistically
evoke
ICD
for
high‐efficiency
tumor‐targeted
immunotherapy.
Although
MOF‐199
widely
used
immunogenicity
unclear.
Pluronic
F127‐modified
NPs
(
F127
NPs)
show
dual‐responsiveness
glutathione
(GSH)
hydrogen
sulfide
(H
2
S).
Once
entering
cancer
cells,
dissociate
GSH‐enriched
microenvironment
(TME)
release
copper
ion
copper‐overload‐mediated
cuproptosis.
Meanwhile,
transform
Cu
2−
x
S
by
situ
sulfidation
under
H
S‐enriched
colorectal
(CRC)
TME.
Under
photothermal
chemodynamic
(PTT/CDT)
NPs,
caspase‐3
activated
gasdermin
E
(GSDME)‐related
triggered.
The
have
proved
superior
antitumor
immunity
effect
both
vitro
vivo
experiments.
This
work
new
strategy
achieve
immunotherapy
with
high
simple
NPs.
Small,
Journal Year:
2024,
Volume and Issue:
20(27)
Published: Feb. 1, 2024
Abstract
Glutathione
(GSH)
is
the
primary
antioxidant
in
cells,
and
GSH
consumption
will
break
redox
balance
cells.
Based
on
this,
a
method
that
uses
high
concentrations
of
tumor
microenvironment
to
trigger
reaction
Cu(II)
generate
copper
nanoprobes
with
fluorescence
growth
inhibition
properties
proposed.
The
nanoprobe
mainly
exists
form
Cu(I)
catalyzes
decomposition
hydrogen
peroxide
into
hydroxyl
radicals.
At
same
time,
simple
controllable
carbon
micro‐nano
electrode
used
construct
single‐cell
sensing
platform,
which
enable
detection
glutathione
content
single
living
cells
after
treatment,
providing
an
excellent
example
for
detecting
biomolecules.
Chemical Reviews,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 14, 2025
Ferroptosis,
an
iron-dependent
form
of
regulatory
cell
death,
has
garnered
significant
interest
as
a
therapeutic
target
in
cancer
treatment
due
to
its
distinct
characteristics,
including
lipid
peroxide
generation
and
redox
imbalance.
However,
clinical
application
oncology
is
currently
limited
by
issues
such
suboptimal
efficacy
potential
off-target
effects.
The
advent
nanotechnology
provided
new
way
for
overcoming
these
challenges
through
the
development
activatable
magnetic
nanoparticles
(MNPs).
These
innovative
MNPs
are
designed
improve
specificity
ferroptosis
induction.
This
Review
delves
into
chemical
biological
principles
guiding
design
ferroptosis-based
therapies
imaging-guided
therapies.
It
discusses
mechanisms
attributes
ferroptosis,
composition
MNPs,
their
mechanism
action
inducers,
integration
with
advanced
imaging
techniques
monitoring.
Additionally,
we
examine
convergence
other
strategies,
chemodynamic
therapy,
photothermal
photodynamic
sonodynamic
immunotherapy,
within
context
nanomedicine
strategies
utilizing
MNPs.
highlights
multifunctional
surpass
limitations
conventional
treatments,
envisioning
future
drug-resistance-free,
precision
diagnostics
treating
recalcitrant
cancers.
Advanced Materials,
Journal Year:
2022,
Volume and Issue:
35(12)
Published: Aug. 23, 2022
Hollow-structured
nanomaterials
(HSNMs)
have
attracted
increased
interest
in
biomedical
fields,
owing
to
their
excellent
potential
as
drug
delivery
systems
(DDSs)
for
clinical
applications.
Among
HSNMs,
hollow
multi-shelled
structures
(HoMSs)
exhibit
properties
such
high
loading
capacity,
sequential
release,
and
multi-functionalized
modification
represent
a
new
class
of
nanoplatforms
The
remarkable
HoMS-based
DDS
can
simultaneously
satisfy
enhance
DDSs
delivering
small
molecular
drugs
(e.g.,
antibiotics,
chemotherapy
drugs,
imaging
agents)
macromolecular
protein/peptide-
nucleic
acid-based
drugs).
First,
the
latest
research
advances
are
summarized
highlight
inherent
advantages
targeting,
combining
continuous
therapeutic
theranostics
optimize
benefit.
Meanwhile,
initial
development
stage
currently
offer
limited
modes.
There
is
growing
need
analyze
deficiency
other
HSNMs
integrate
providing
solutions
safe,
stable,
cascade
meet
vast
treatment
requirements.
Therefore,
comprehensively
reviewed,
mainly
focusing
on
characteristics,
progress
by
category,
future
prospects.
Nano Letters,
Journal Year:
2022,
Volume and Issue:
22(20), P. 8321 - 8330
Published: Oct. 12, 2022
Ti3C2-MXene-based
composites
provide
multifunctional
interfaces
in
diagnosis
and
treatment
of
tumors.
Herein,
we
proposed
a
nanoplatform
based
on
Ti3C2-MXene–Au
nanocomposites,
which
combines
photothermal
properties
peroxidase-like
activity,
accomplishing
synergistic
therapy
(PTT)
enzyme
dynamic
(EDT)
accompanied
by
photoacoustic
(PA)
thermal
dual-mode
imaging
vivo.
Furthermore,
PTT
induces
immunogenic
cell
death,
EDT
promotes
apoptosis,
facilitating
dendritic
(DC)
maturation
T
infiltration
into
the
tumor.
On
this
basis,
antibody
OX40
(αOX40)
was
utilized
to
further
contribute
immune
for
reversing
immunosuppressive
tumor
microenvironment
activating
CD4+
CD8+
cells.
In
summary,
triune
PTT/EDT/antitumor
is
achieved
combining
nanocomposites
αOX40,
possesses
several
strong
features
good
biocompatibility,
NIR-controlled
targeting,
significant
cancer
killing,
satisfactory
biosafety
vitro
Our
work
might
highlight
promising
application
MXene-based
nanoplatforms
therapy.